Prepare Now for the Next Financial Storm

Prepare Now for the Next Financial Storm
By Christopher Ure Climate scientists have been warning that extreme weather would become more frequent and intense, yet the 2017 hurricane season and this winter still seem like a brutal wake-up call to nature’s extraordinary power. The frightening possibilities turned into realities across large areas of our country where monumental hurricanes struck the Houston area, Puerto Rico, the Florida Keys, the... Read More

Investors Penalize Exxon Mobil For Missing Consensus Estimate

Investors Penalize Exxon Mobil For Missing Consensus Estimate
Exxon Mobil ( XOM ), the world’s largest publicly traded oil and gas company, posted a strong improvement in its financial performance for the December quarter and full year 2017 on 2nd February 2018(( Exxon Mobil Announced December Quarter Results , www.exxonmobil.com)). While the company’s top-line and earnings recovered, backed by the rebound in commodity prices, the company missed the... Read More

Why Chesapeake Energy Corporation's Stock Tumbled Another 11.6% in January

Why Chesapeake Energy Corporation's Stock Tumbled Another 11.6% in January
What happened Chesapeake Energy Corporation (NYSE: CHK) limped into 2018 after its stock plunged more than 40% last year due to its continued financial troubles. Shares of the natural gas producer haven’t fared any better this year, slumping another 11.6% last month, according to data provided by S&P Global Market Intelligence . Driving the latest sell-off was the announcement that... Read More

3 Things to Really Like About Bristol-Myers Squibb's Q4 Earnings Results

3 Things to Really Like About Bristol-Myers Squibb's Q4 Earnings Results
When Bristol-Myers Squibb (NYSE: BMY) reported its third-quarter earnings results in October, some investors might have wondered if they needed to worry. The big pharma company posted a year-over-year earnings decline even worse than what Wall Street expected. However, those results weren’t as bad as they seemed at first glance. Bristol-Myers Squibb announced its fourth-quarter and full-year 2017 results before the... Read More